Oil for Life to Balance omega-3 polyunsaturated fatty acids ... - Oil4Life

� Neuringer M, Reisbick S., Janowsky. (1994) The role of n-3 fatty acids in visual
and cognitive development: current evidence and methods of assessment. J. Pediatr.
125: 39– 47.
� Nishizawa H., Hamazaki K., Hamazaki T., Fujioka S., Sawazaki S. (2006) The
relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo 20
(2): 307-310.
� Nordoy A. (2002) Statins and omega-3 fatty acids in the treatment of dyslipidemia
and coronary heart desease. Minerva Med. 93: 357– 63.
� Norrish A., Skeaff C., Arribas G., Jackson R. (1999) Prostate cancer risk and
consumption of fish oils: dietary biomarker-based case-control study. Br. J. Cancer
81: 1238-1242.
� Nuttal F.Q., Gannon M.C., Saeed A., Jordan K., Hoover H. (2003) The metabolic
response of subjects with type 2 diabetes to a high-protein, weight-maintenance diet.
J. Clin. Endocrinol. Metab. 88: 3577– 83.
� O'Brien W.F., Krammer J., O'Leary T.D., Mastrogiannis D.S. (1993). "The
effect of acetaminophen on prostacyclin production in pregnant women". Am. J.
Obstet. Gynecol. 168 (4): 1164–9.
� Oliewiecki S., Burton J.L., Elles K., Horrobin D.F. (1990) Levels of essential and
other fatty acids in plasma and red cell phospholipid from normal controls and
patients with atopic eczema. Acta Derm. Venoral. 71: 224-228.
� Owen R.W., Giacosa A., Hull W.E., Haubner R., Wurtele G., Spiegelhalder B.,
Bartsch H. (2000) Olive-oil consumption and health: the possible role of
antioxidants. Lancet Oncol. 1:107-112.
� Pariza M. (1997) Animal studies: summary, gaps, and future research. Am. J. Clin.
Nutr. 66S: 1539-1540.
� Parra M.S., Schnaas L., Meydani M., Perroni E. (2002) Erythrocyte cell
membrane phospholipids levels compared against reported dietary intakes of
polyunsaturated fatty acids in pregnant Mexican women. Public Health Nutrition 5:
931-937.
� Pawlosky R., Hibben J., Wegher B., Sebring N., Salem J. (1999) The effects of
cigarette smoking on the metabolism of essential fatty acids. Lipids 34: S287.
� Peet M., Brind J., Ramchand C.N., Shah S., Vankar K.G. (2001) Two doubleblind
placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of
schizophrenia. Schizoph. Res. 49: 243-251.
� Peet M., Laugharne J., Rangarajan N., Horrobin D., Reynolds G. (1995)
Depleted red cell membrane essential fatty acids in drug-treated schizophrenic
patients. J. Psychiatr. Res. 29: 227-232.
� Peet M., Laugharne J.D., Horrobin D.F., Reynolds G.P. (1994) Arachidonic acid:
a common link in the biology of schizophrenia? Arch. Gen. Psychiatry. 51: 665-666.
� Peet M., Murphy B., Shay J., Horrobin D. (1998) Depletion of omega-3 fatty acid
levels of depressive patients. Biol. Psychiatry 43: 315-319.
� Pelikanova T., Kohout M., Valek J., Base J., Kazdova L. (1989) Insulin secretion
and insulin action related to the serum phospholipid fatty acid pattern in healthy men.
Metabolism 38: 188-192.
� Pereira M.A., Swain J., Goldfine A.B., Rifai N., Ludwing D.S. (2004) Effects of a
low-glycemic load diet on resting energy expenditure and heart disease risk factor
during weight loss. JAMA 292: n 20.
� Pliszka S.R., Maas J.W., Javors M.A., Rogeness G.A., Baker J. (1994) Urinary
catecholamines in attention-deficit hyperactivity disorder with and without comorbid
43